Skip to main content
Canada’s most-awarded newsroom for a reason
Enjoy unlimited digital access
$1.99
per week
for 24 weeks
Canada’s most-awarded newsroom for a reason
$1.99
per week
for 24 weeks
// //

Dr. Deborah Persaud of the Johns Hopkins Children’s Center in Baltimore made the announcement that a baby had been ‘functionally cured’ of HIV.

The Associated Press

The announcement by U.S. researchers last weekend that a Mississippi infant has been cured of HIV is still generating excitement around the world. It's unclear, however, how and if that development will help scientists eradicate the disease. A cure has not been found.

U.S. researchers told an AIDS meeting in Atlanta on Sunday they had successfully cured the baby through an aggressive cocktail of drugs that were first administered within about 30 hours of the child's birth. When the baby was 18 months old, her mother stopped the treatments and missed several appointments. After they resurfaced, doctors tested the girl and discovered that the virus was virtually gone.

Now, 10 months after treatment was stopped, the girl has been declared "functionally cured," meaning that there are only traces of the virus's genetic material in her blood. However, doctors will continue to monitor her to see if the virus returns. The scientists did not disclose the baby's name or reason why the mother discontinued treatment.

Story continues below advertisement

The unique nature of the situation means that it is unlikely to lead to a major breakthrough, at least in the near future. The infant's mother learned that she had the human immunodeficiency virus when she was in labour at the hospital. Typically, expectant women with HIV take antiretroviral drugs, which dramatically reduces the possibility of transmission to the child. Because that did not occur in this case, doctors instead chose to give the infant a strong drug cocktail hours after birth to fight the virus.

While this could open up exciting treatment options for other infants and children infected with HIV, researchers say it does not mean that a cure is on the horizon. That is because they still don't know how to fight the dormant reservoirs of the virus that hide in the cells of infected individuals. These reservoirs are established after a person contracts the virus; they don't go away, even if the person is taking antiretroviral drugs. The medication can stop the virus from actively replicating and helps to stop progression. But if a person stops taking antiretroviral therapy, the latent HIV reservoirs start replicating again.

In the case of the Mississippi girl, doctors believe that because her drug therapy was started so quickly after transmission, virus reservoirs did not have the chance to form, which is why the virus is no longer detectable.

Mark Wainberg, a prominent HIV/AIDS researcher based at Montreal's Jewish General Hospital and McGill University, said her case makes a strong argument for early, aggressive treatment to help those infected with HIV. But in many cases, that may not be realistic. For instance, individuals may not learn that they are infected with the virus for months or even years.

"We need to find a way, in the vast vast majority of cases, of going after these populations of cells that represent this reservoir," he said. "That's something we still don't know how to do."

For that reason, researchers are cautious about whether the news of a "cure" will result in changes that can help others. Chil-Yong Kang, professor of virology at the Schulich School of Medicine and Dentistry at the University of Western Ontario, said he wants to understand how the cells infected by the latent virus were cleared. The girl in Mississippi "really opens that question," but doesn't provide many answers.

Until more is known, they are urging patients to proceed with caution and to continue adhering to their drug-treatment schedules. "This should not be taken by anyone to say that gee, one can have a complacent approach to how HIV is managed," said Upton Allen, chief of infectious diseases at the Hospital for Sick Children in Toronto.

Story continues below advertisement

At the same time, it is unclear whether the aggressive cocktail of drugs given to the infant will have long-term effects on her development. While her case may help other children infected with HIV, it's important not to dismiss the potential seriousness of side effects, Allen said.

But the work will continue, Wainberg said, so that researchers can find answers to those questions. "I really do feel that we're getting closer every single day to having a real cure," he said.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow the author of this article:

View more suggestions in Following Read more about following topics and authors
Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies